Core Points - Kinepolis Group NV held its Ordinary General Meeting on 14 May 2025, where all proposed agenda items were approved [1] Group 1 - The minutes of the meeting are available for consultation on the Kinepolis Group website [1]

Core Points - The Company will enter a closed period effective from 20 May 2025 until the publication of its half-year results on or around 19 June 2025 [2] - The Company has ensured that any inside information held by the Directors or the Company during the closed period has been previously disclosed to a regulatory information service, allowing for the repurchase or issuance of securities during this time [3] - Should the Directors acquire any inside information before the announcement of the half-year results, it will be promptly notified to the London Stock Exchange prior to any transactions [4]

Core Points - Falcon Oil & Gas Ltd. has filed its interim financial statements for the three months ended 31 March 2025, along with the Management's Discussion and Analysis [2][3] Financial Highlights - For Q1 2025, Falcon reported no revenue from oil and natural gas [7] - Exploration and evaluation expenses decreased to $40,000 from $44,000 year-over-year [7] - General and administrative expenses decreased to $491,000 from $528,000 year-over-year [7] - Foreign exchange gain was $77,000 compared to $120,000 in Q1 2024 [7] - The net loss for the period was $497,000, an improvement from a loss of $806,000 in Q1 2024 [7][11] - The company had cash of $6.9 million at 31 March 2025, slightly up from $6.8 million at 31 December 2024 [8] Financial Position - Total assets as of 31 March 2025 were $62.561 million, compared to $62.241 million at 31 December 2024 [10] - Non-current assets increased to $55.526 million from $52.387 million [10] - Total equity decreased to $44.168 million from $44.665 million [10] Cash Flow - Net cash used in operating activities was $622,000, compared to $611,000 in Q1 2024 [11] - Net cash generated from investing activities was $605,000, a significant improvement from a cash outflow of $2.861 million in Q1 2024 [11] - Cash and cash equivalents at the end of the period were $6.896 million, up from $4.289 million at the end of Q1 2024 [11]

Core Insights - Dékuple Group has announced a partnership with After, a creative agency in Barcelona, as part of its international growth strategy to enhance its European presence and expertise in creativity and engagement marketing [2][4][10] Group Expansion Strategy - The integration of After strengthens Dékuple's foothold in the Iberian market, where it has been active for over 20 years through Dékuple Ibéria and Converteo [3][11] - This merger follows recent expansions in Germany and the Netherlands, aligning with Dékuple's 2030 ambition to become a European leader in communication and data marketing [4][12] Synergies and Operational Model - The partnership aims to leverage synergies and complementary expertise while maintaining an agile, multi-entrepreneurial model that allows each entity to retain its management and operational independence [5][10] - By combining After's creative strengths with Dékuple's technological and data-driven expertise, the Group seeks to deliver effective marketing solutions tailored to local cultural specifics [6][10] After Agency Overview - After, founded in 2007, is recognized as one of the top three independent agencies in Spain, known for its storytelling and advertising innovation [7][8] - The agency offers comprehensive services from strategy to execution, emphasizing social and environmental impact in its campaigns [8] Financial Performance - After generates annual net sales exceeding €10 million and a gross margin of more than €5 million, and will be consolidated into Dékuple's accounts starting May 1, 2025 [12]

Core Insights - Caledonia Mining Corporation has published its 2024 ESG Report, highlighting its commitment to sustainability and strategic responses to climate-related challenges [1][2]. Group 1: ESG Strategy and Implementation - The company has completed a comprehensive climate change risk assessment to understand the potential impacts of extreme weather, water stress, energy security, and regulatory changes on its operations [3]. - Caledonia has elevated its sustainability reporting standards by undertaking an IFRS Sustainability Standards readiness assessment and starting an Equator Principles gap analysis to ensure compliance with high standards [4]. Group 2: Community Investment and Long-term Value - The company is focused on delivering long-term value through responsible operations and has invested in community initiatives, including the installation of solar energy infrastructure for local schools and clinics, and prioritizing local procurement to enhance regional economic development [5].

Core Viewpoint - AB Science S.A. successfully completed a private placement raising EUR 1.8 million to finance ongoing activities, particularly focusing on the clinical development of the AB8939 program [1][3]. Group 1: Private Placement Details - The private placement involved the issuance of 1,538,463 new ordinary shares, each with one share warrant attached, without preferential subscription rights [4]. - The issue price of one ABSA was set at EUR 1.17, reflecting a 24.8% discount to the volume-weighted average price over the three trading days prior [6][7]. - The total share capital post-placement will be EUR 661,764.30, comprising 59,368,757 ordinary shares, with potential increases if all BSAs are exercised [11]. Group 2: Use of Proceeds - The net proceeds from the private placement will primarily be allocated to the clinical development of the AB8939 program [3]. Group 3: Shareholder Impact - The issuance of ABSAs will result in a dilution of existing shareholders' stakes, with specific percentages outlined for major shareholders before and after the placement [12][14]. - The theoretical value of each BSA is estimated at EUR 0.4053, based on a volatility of 34.355% [9]. Group 4: Trading and Listing - The new shares are expected to be admitted to trading on Euronext Paris on May 22, 2025, and will be assimilated to existing shares [16]. - The BSAs are anticipated to be listed on Euronext Growth Paris by May 26, 2025 [10]. Group 5: Company Overview - AB Science specializes in the research, development, and commercialization of protein kinase inhibitors, targeting diseases with high unmet medical needs [25]. - The lead compound, masitinib, is being developed for various medical applications, including oncology and inflammatory diseases [25][23].

Core Points - ForFarmers N.V. has completed its share buy-back programme, repurchasing a total of 400,000 shares for €1,675,903 [2] - The last repurchase occurred on 19 May 2025, with 37,881 shares bought at an average price of €4.36 per share [1] - The buy-back was authorized by the Annual General Meeting of Shareholders on 17 April 2025, aimed at fulfilling obligations from share-related incentive schemes [1] Company Profile - ForFarmers is a leading provider of complete feed solutions for (organic) livestock farming, with a mission to contribute to sustainable agriculture [4] - The company sells approximately 9 million tonnes of animal feed annually and operates production facilities in the Netherlands, Germany, Poland, and the UK [5] - ForFarmers employs around 2,700 people and is listed on Euronext Amsterdam [5]

Press Release CROSSJECT prepares for the launch of a capital increase with preferential subscription rights of around 5 million euros in preparation for commercial and production activities linked to EUA approval The amount of the proposed transaction (“the Offer”) might be increased to around 5.8 million euros if the extension clause is exercised;Gemmes Venture, the Company's reference shareholder, announced its intention to guarantee the capital increase in cash up to the amount required for its completio ...

Bíldudalur, 20 May 2025 Icelandic Salmon is the parent company of Arnarlax and its subsidiaries, which are involved in salmon farming and processing in Iceland. The companies are collectively referred to as "Icelandic Salmon" or the "Group". In the first quarter, Icelandic Salmon experienced biological challenges at sea. To protect animal welfare, some volumes were harvested early at low average weights. Results were marked by mortality-related costs, low harvest volumes, and a weaker market due to increase ...

Aalberts today reports that it has repurchased 2,500 of its own shares in the period from 12 May 2025, up to and including 16 May 2025, for an amount of EUR 77,447.70, so at an average share price of EUR 30.98. This is part of the share buyback programme as announced on 27 February 2025, for a total amount of EUR 75 million. The repurchase of shares commenced on 28 February 2025 and will be completed no later than 24 October 2025. It is intended that the shares will be cancelled following repurchase. Up to ...